P. Roy Vagelos, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 78,897 shares at $650.04 ($13.1M) on 2021-08-18, disclosed to the SEC on 2021-08-19.
Open-market sale of $13.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 446 | $0 | 0.0% |
| 2 | $0.00 | 22,000 | $0 | 0.0% |
| 3 | $0.00 | 19,000 | $0 | 0.0% |
| 4 | $0.00 | 373 | $0 | 0.0% |
| 5 | $0.00 | 17,000 | $0 | 0.0% |
| 6 | $650.04 | 10,039 |
| $6.5M |
| 50.0% |
| 7 | $650.04 | 10,039 | $6.5M | 50.0% |
| Total | $165.42 avg | 78,897 | $13.1M | 100% |
| Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |
| REGN | SELL | 2019-12-13 | $19.5M | — | Filing → |